Skip to content

Author

T. Biering-Sørensen

10 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

CIED-derived sleep apnea burden and risk of heart failure hospitalization: a registry-based analysis

Sleep apnea is a highly prevalent yet frequently underdiagnosed comorbidity in heart failure (HF). Cardiac implantable electronic devices (CIEDs) offer a pragmatic approach for continuous screening without additional procedures or costs. We retrospectively analyzed registry-based data to evaluate the relationship...

T. Bekfani, J. Christensen, J. Simonsen et al. · 0 citations
Oct 2026

Effect of Colchicine on Arterial Stiffness in Patients With Hypertension: The COlchicine HypERtENsion Trial (COHERENT).

AIM This trial investigated whether colchicine, an anti-inflammatory treatment, affects cardiovascular structure and function, assessed by arterial stiffness, blood pressure and biochemistry, compared with placebo. METHODS COHERENT was a randomized, double-blind, placebo-controlled trial of the effects of colchicine...

A. Langhoff, N. Johansen, K. Bartholdy et al. · 0 citations
Review Aug 2026

Comparative effectiveness of influenza vaccination dosing strategies for cardiovascular protection: a systematic review and network meta-analysis of randomised controlled trials.

BACKGROUND Influenza vaccination is recommended for cardiovascular secondary prevention, but the comparative effectiveness of different dose strategies remains incompletely characterised. METHODS We searched MEDLINE, Embase, and CENTRAL for randomised trials comparing high-dose (HD-IIV), double standard-dose, standar...

Joshua J. Hon, T. Aikawa, T. Biering-Sørensen et al. · 0 citations
Open access Aug 2026

Serial high-sensitivity troponin-T and risk of heart failure in individuals with suspected acute coronary syndrome.

AIMS To investigate the association between serial high-sensitivity cardiac troponin-T (hs-TnT) concentrations and subsequent heart failure in individuals presenting with suspected acute coronary syndrome (ACS). METHODS AND RESULTS Utilizing Danish nationwide registries, we identified individuals without known heart...

Philip Ahle Erichsen, Majid Afzal, Christina Byrne et al. · 1 citation
Aug 2026

Bivalent RSV Prefusion F Vaccine to Prevent Hospitalizations in Adults.

BACKGROUND Respiratory syncytial virus (RSV) is an important cause of severe respiratory disease in adults, with the highest burden among older adults and individuals with chronic health conditions. The bivalent RSV prefusion F (RSVpreF) vaccine has been shown to prevent RSV-associated respiratory illness, but data fro...

M. Lassen, S. Christensen, M. Yafasov et al. · 1 citation
Open access

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty...

C. Espersen, N. Johansen, D. Modin et al. · 0 citations
Open access Sep 2026

Sex differences in acute heart failure: Clinical presentation, imaging findings, and short-term recovery.

BACKGROUND Sex differences in chronic heart failure are well established, but corresponding differences in acute heart failure (AHF), particularly in multimodal imaging findings and short-term recovery, remain incompletely characterized. METHODS In this prospective observational study, 567 adults hospitalized with AH...

A. Khoraizat, F. Davidovski, C. Espersen et al. · 0 citations
#protein folding Open access Oct 2026

RSV prefusion F vaccine effectiveness in older adults with immunosuppression: a prespecified analysis of the DAN-RSV trial.

In adults aged 60 years or older, RSVpreF vaccination reduced hospitalisations for RSV-related respiratory tract disease with no statistical evidence of effect modification by immunosuppression status; however, the study was not powered to exclude subgroup differences.

A. Reimer Jensen, M. H. Højbjerg Lassen, N. Johansen et al. · 0 citations
Open access Sep 2026

Cardiac Structure and Function and Pulmonary Congestion Across New York Heart Association Classes in Patients With Acute Heart Failure

Acute heart failure (AHF) is a major global health challenge, yet the relationship between New York Heart Association (NYHA) classification and objective markers such as echocardiography, lung ultrasound (LUS), and biomarkers remains unclear.

A. Al-Rubai, F. Davidovski, C. Espersen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.